These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34562546)

  • 1. Evaluation of the Amplex eazyplex SuperBug Acineto test for direct detection of multi-drug-resistant Acinetobacter baumannii bloodstream infections in high endemicity settings.
    Comini S; Bianco G; Boattini M; Iannaccone M; Casale R; Banche G; Cavallo R; Costa C
    J Hosp Infect; 2021 Nov; 117():179-181. PubMed ID: 34562546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application progress of polymyxin in bloodstream infection of drug-resistant Acinetobacter baumannii].
    Zhang S; Sun L; Sun L; Yang Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1401-1404. PubMed ID: 34980319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii: Acinetobacter baumannii therapeutics.
    Gallagher P; Baker S
    J Infect; 2020 Dec; 81(6):857-861. PubMed ID: 33115656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination.
    Zaidan N; Hornak JP; Reynoso D
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0092421. PubMed ID: 34370576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissemination of Acinetobacter baumannii OXA-23 in old and new intensive care units without transfer of colonized patients.
    Brondani Moreira RR; Viana GF; de Moraes ACC; de Souza Bastos M; Nishiyama SAB; Dos Anjos Szczerepa MM; Cardoso CL; Tognim MCB
    Infect Control Hosp Epidemiol; 2018 Sep; 39(9):1135-1137. PubMed ID: 30060773
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple sequence types responsible for healthcare-associated Acinetobacter baumannii dissemination in a single centre in Egypt.
    Al-Hassan L; Zafer MM; El-Mahallawy H
    BMC Infect Dis; 2019 Oct; 19(1):829. PubMed ID: 31590644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
    Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant Acinetobacter baumannii, Russia.
    Naas T; Kernbaum S; Allali S; Nordmann P
    Emerg Infect Dis; 2007 Apr; 13(4):669-71. PubMed ID: 17561578
    [No Abstract]   [Full Text] [Related]  

  • 9. OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.
    Yang Y; Xu Q; Li T; Fu Y; Shi Y; Lan P; Zhao D; Chen Q; Zhou Z; Jiang Y; Peleg AY; Yu Y
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348663
    [No Abstract]   [Full Text] [Related]  

  • 10. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
    Pan CY; Chen JC; Chen TL; Wu JL; Hui CF; Chen JY
    Mar Drugs; 2015 Apr; 13(4):2287-305. PubMed ID: 25874924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Metallo-β-Lactamases in Acinetobacter Baumannii in Iran: A Review and Meta-Analysis.
    Mohammadpour B; Rouhi S; Moradi M; Ramazanzadeh R; Saniyi E; Zandi S; Salimizand H
    Infect Disord Drug Targets; 2019; 19(4):350-361. PubMed ID: 30324896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant
    Ranjbar R; Farahani A
    Antimicrob Resist Infect Control; 2019; 8():172. PubMed ID: 31719975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Strategy for Post-Operative Patients with Central Nervous System Infections Caused by Extensively Drug-Resistant/Pan-Drug-Resistant
    Chang JB; Chen Y; Wang H; Ma X; Zhang X; Wu H; Ma B; Zuo W; Ma W; Wang R; Wei J
    Surg Infect (Larchmt); 2020 Dec; 21(10):853-858. PubMed ID: 32302500
    [No Abstract]   [Full Text] [Related]  

  • 14. Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013.
    Decousser JW; Jansen C; Nordmann P; Emirian A; Bonnin RA; Anais L; Merle JC; Poirel L
    Euro Surveill; 2013 Aug; 18(31):. PubMed ID: 23929226
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ellis RC; Roberts EK; Grier JT; Fiester SE
    Future Microbiol; 2022 Nov; 17():1345-1347. PubMed ID: 36200659
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Colistin and Sulbactam Combination Effectivity in Multi Drug Resistant Acinetobacter baumannii Strains with Diagonal Gradient Strip Test Method.
    Hatipoglu H; Kilbas I; Kilic U; Yilmaz K; Koroglu M; Altindis M
    Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549991
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
    Poirel L; Nordmann P
    Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.
    Poirel L; Bonnin RA; Nordmann P
    IUBMB Life; 2011 Dec; 63(12):1061-7. PubMed ID: 21990280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Genome Analysis of Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates in Thailand.
    Chopjitt P; Kerdsin A; Takeuchi D; Hatrongjit R; Boueroy P; Akeda Y; Tomono K; Hamada S
    Infect Disord Drug Targets; 2021; 21(5):e270421188042. PubMed ID: 33200701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.